Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 1.00 |
| ▸ | CA2 | P00918 | 8/20 | 1.00 |
| ▸ | CA9 | Q16790 | 7/20 | 1.00 |
| ▸ | CA12 | O43570 | 6/20 | 1.00 |
| ▸ | CA4 | P22748 | 4/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29523041 | 1.00 | CA1 (1.00) | CA1CA2CA9CA12CA4 | |
| Hydrochloric Acid SCHEMBL1164812 | 0.98 | CA1 (0.96) | CA1CA2CA9CA12CA4 | |
| SCHEMBL11886709 | 0.85 | CA1 (0.73) | CA1CA2CA9CA12CA4 | |
| SCHEMBL2279747 | 0.82 | CA1 (0.69) | CA1CA2CA9CA12CA4 | |
| SCHEMBL3475067 | 0.82 | KLK1 (0.69) | CA1CA2CA9CA12 | |
| SCHEMBL12317636 | 0.81 | CA1 (0.69) | CA1CA2CA9CA12CA4 | |
| Hydrochloric Acid SCHEMBL2287113 | 0.81 | CA1 (0.67) | CA1CA2CA9CA12CA4 | |
| Hydrochloric Acid SCHEMBL19838208 | 0.80 | CA1 (0.67) | CA1CA2CA9CA12CA4 | |
| SCHEMBL1135299 | 0.80 | CA12 (0.65) | CA1CA2CA9CA12 | |
| SCHEMBL1135328 | 0.78 | CA1 (0.65) | CA1CA2CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120641-A | Synthesis method of multifunctional composite hydrogel for promoting diabetic wound repair | 深圳市人民医院 | 2023-05-16 | — | — | CN | claimed |
| CN-113209375-B | Preparation method and application of hydrogel based on arylborate crosslinking and having self-repairing and injectable properties | 温州医科大学 | 2023-01-06 | — | — | CN | claimed |
| US-20260008791-A1 | CHEMICAL COMPOUNDS | BORAH INC (US) | 2026-01-08 | — | — | US | disclosed |
| WO-2025235840-A1 | ECHINOCANDIN-LIKE AND BORON-CONTAINING ECHINOCANDIN COMPOUNDS AND THEIR USE AS AGROCHEMICAL FUNGICIDES | 5METIS, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| US-12358932-B2 | Chemical compounds | BORAH, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-12264169-B2 | Heteroaryl inhibitors of PDE4 | Tetra Discovery Partners (US) | 2025-04-01 | — | — | US | disclosed |
| US-20240368196-A1 | CHEMICAL COMPOUNDS | BORAH, INC. | 2024-11-07 | — | — | US | disclosed |
| US-20240358728-A1 | BORON CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | ANACOR PHARMACEUTICALS, LLC (US) | 2024-10-31 | — | — | US | disclosed |
| CN-114292274-B | Pyrrolo [2,3-d ] pyrimidine derivatives as JAK kinase inhibitors, and preparation method and application thereof | 中国药科大学 | 2023-12-19 | — | — | CN | disclosed |
| US-11834466-B2 | Benzoxaborole compounds and formulations thereof | 5METIS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| US-11834466-B2 | Benzoxaborole compounds and formulations thereof | 5METIS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| WO-2007078340-A2 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | WO | disclosed |
| US-20070155699-A1 | Boron-containing small molecules | ANACOR PHARMACEUTICALS (US) | 2007-07-05 | — | — | US | disclosed |
| US-20070155699-A1 | Boron-containing small molecules | ANACOR PHARMACEUTICALS (US) | 2007-07-05 | — | — | US | disclosed |
| US-20070155699-A1 | Boron-containing small molecules | ANACOR PHARMACEUTICALS (US) | 2007-07-05 | — | — | US | disclosed |
| WO-2006079843-A1 | SENSOR MOLECULES INCORPORATING A BORONIC ACID SENSOR GROUP | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2006-08-03 | — | — | WO | disclosed |
| CN-1068005-C | Oxaboroles and salts thereof, and thire use as biocides | ZENECA LTD (GB) | 2001-07-04 | — | — | CN | disclosed |
| EP-0765331-B1 | OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES | AVECIA LTD (GB) | 2000-08-09 | — | — | EP | disclosed |
| US-5880188-A | PROTECTING MEDIUM SUSCEPTIBLE TO MICROBIAL ATTACK BY TREATING WITH SPECIFIED OXABOROLE COMPOUND | ZENECA LIMITED (GB) | 1999-03-09 | — | — | US | disclosed |
| CN-1155286-A | Oxaboroles and salts thereof, and thire use as biocides | ZENECA LTD (GB) | 1997-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008791-A1 | CHEMICAL COMPOUNDS | JAK3, JAK2, JAK1 | CA1 2589/4885CA2 835/4885CA9 1242/4885 |
| US-20240358728-A1 | BORON CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | NFKBIA, LITAF, LRBA | CA1 1683/4885CA2 773/4885CA9 931/4885 |
| US-20240368196-A1 | CHEMICAL COMPOUNDS | PDE4A, PDE4B, SYK | CA1 4260/4885CA2 1841/4885CA9 1766/4885 |
| US-11834466-B2 | Benzoxaborole compounds and formulations thereof | SSB, NONO, LRBA | CA1 3230/4885CA2 1593/4885CA9 2411/4885 |
| US-20070155699-A1 | Boron-containing small molecules | ETF1, POLR1C, DPM1 | CA1 4091/4885CA2 1368/4885CA9 980/4885 |
| US-12264169-B2 | Heteroaryl inhibitors of PDE4 | PDE4A, PDE4B, PDE4C | CA1 4346/4885CA2 2235/4885CA9 2390/4885 |
| US-12358932-B2 | Chemical compounds | PDE4A, PDE4B, SYK | CA1 4260/4885CA2 1841/4885CA9 1766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.